Virus News and Research

Latest Virus News and Research

Cannabis Science commences CSTATI-1 preclinical studies in Squamous/BCCs, Kaposi's sarcoma

Cannabis Science, a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.

24 Sep 2012

FSU researcher to explore gene-controlling effects of addictive drugs in pursuit of new HIV treatments

A Florida State University researcher is on a mission to explore the gene-controlling effects of addictive drugs in pursuit of new HIV treatments.

24 Sep 2012

Newly discovered Eilat virus harmless and potentially valuable

A mosquito sample collected three decades ago in Israel's Negev Desert has yielded an unexpected discovery: a previously unknown virus that's closely related to some of the world's most dangerous mosquito-borne pathogens but, curiously, incapable of infecting non-insect hosts.

24 Sep 2012

Transmitted HIV strains may have evolutionary advantage, suggest scientists

A new study has found that even though HIV diversifies widely within infected individuals over time, the virus strains that ultimately are passed on through heterosexual transmission often resemble the strain of virus that originally infected the transmitting partner.

24 Sep 2012

WHO working with partners to stop Ebola from spreading in DRC

The WHO on Tuesday "said it is continuing to work with authorities from the Democratic Republic of the Congo (DRC) to stop an Ebola outbreak from spreading, with the number of detected cases having reached 46 in the past week," the U.N. News Centre reports.

20 Sep 2012

Study uncovers why some HIV-positive people take long time to progress to full-blown AIDS

One of the big mysteries of AIDS is why some HIV-positive people take more than a decade to progress to full-blown AIDS, if they progress at all.

20 Sep 2012

Complete story behind connection between XMRV virus and prostate cancer

A once-promising discovery linking prostate cancer to an obscure retrovirus derived from mice was the result of an inadvertent laboratory contamination, a forensic analysis of tissue samples and lab experiments - some dating back nearly a decade - has confirmed.

20 Sep 2012

Viral cause excluded for chronic fatigue syndrome

New research suggests that chronic fatigue syndrome does not occur as a result of infection with xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus.

19 Sep 2012

Viewpoints: Dragging the 'C word' -- cost -- out of hiding; Elton John on discrimination against state prisoners with HIV

We need death panels. Well, maybe not death panels, exactly, but unless we start allocating health care resources more prudently -- rationing, by its proper name -- the exploding cost of Medicare will swamp the federal budget.

18 Sep 2012

BACE2 enzyme could represent powerful new tool against Alzheimer's

An enzyme that could represent a powerful new tool for combating Alzheimer's disease has been discovered by researchers at Mayo Clinic in Florida. The enzyme - known as BACE2 - destroys beta-amyloid, a toxic protein fragment that litters the brains of patients who have the disease.

18 Sep 2012

No association between XMRV/pMLV and chronic fatigue syndrome

The causes of chronic fatigue syndrome (CFS) have long eluded scientists. In 2009, a paper in the journal Science linked the syndrome-sometimes called myalgic encephalomyelitis (ME)-to infection with a mouse retrovirus called XMRV (xenotropic murine leukemia virus (MLV)-related virus).

18 Sep 2012

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

Immune Targeting Systems Limited, an emerging leader in the development of vaccines that promote T-cell responses against viruses and cancers, today announces compelling data from two Phase I clinical trials of FlunisynTM, the Company's lead vaccine programme which elicits potent immune responses against multiple strains of influenza-A virus.

18 Sep 2012

New test to assess viral load of cytomegalovirus

Roche announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for solid organ transplantation.

From Roche Sequencing and Life Science 17 Sep 2012

Scientists solve co-crystal structure of human antibody that can neutralize influenza viruses

Scientists from The Scripps Research Institute and Sea Lane Biotechnologies have solved the co-crystal structure of a human antibody that can neutralize influenza viruses in a unique way.

17 Sep 2012

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, presented Phase 2 clinical data of JX-594 delivered first intravenously and subsequently through intra-tumoral route demonstrating safety as well as disease control and tumor responses in patients with hepatocellular carcinoma (liver cancer, HCC).

17 Sep 2012

Ebola outbreak in DRC responsible for as many as 31 deaths, according to revised count

"An outbreak of Ebola hemorrhagic fever has claimed possibly as many as 31 lives in the northeast of the Democratic Republic of Congo since May, Health Minister Felix Kabange Numbi said Thursday," Agence France-Presse reports.

15 Sep 2012

Clinical trial results signal 'promise, unresolved challenges' in finding effective dengue vaccine

The first-ever results from a dengue virus vaccine clinical trial aimed at showing effectiveness "provide signals rather than definitive answers, and a mixture of both promise and unresolved challenges," Orin Levine, executive director of the International Vaccine Access Center, and Ciro de Quadros, executive vice president of the Sabin Vaccine Institute, write in the Huffington Post "Impact" blog.

14 Sep 2012

Researchers clone T-cell receptor that binds to antigens associated with prostate and breast cancer

Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells.

14 Sep 2012

Study: 172K polymorphism makes certain forms of HIV less resistant to drugs

The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.

14 Sep 2012

WHO says Nigeria not on track to turn back polio despite having tools, capacity

"The World Health Organization (WHO) on Tuesday said Nigeria was not on track in the effort to eradicate wild polio virus before the end of December this year," Leadership/AllAfrica.com reports.

13 Sep 2012

Virus News and Research

Latest Virus News and Research

Cannabis Science commences CSTATI-1 preclinical studies in Squamous/BCCs, Kaposi's sarcoma

FSU researcher to explore gene-controlling effects of addictive drugs in pursuit of new HIV treatments

Newly discovered Eilat virus harmless and potentially valuable

Transmitted HIV strains may have evolutionary advantage, suggest scientists

WHO working with partners to stop Ebola from spreading in DRC

Study uncovers why some HIV-positive people take long time to progress to full-blown AIDS

Complete story behind connection between XMRV virus and prostate cancer

Viral cause excluded for chronic fatigue syndrome

Viewpoints: Dragging the 'C word' -- cost -- out of hiding; Elton John on discrimination against state prisoners with HIV

BACE2 enzyme could represent powerful new tool against Alzheimer's

No association between XMRV/pMLV and chronic fatigue syndrome

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

New test to assess viral load of cytomegalovirus

Scientists solve co-crystal structure of human antibody that can neutralize influenza viruses

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Ebola outbreak in DRC responsible for as many as 31 deaths, according to revised count

Clinical trial results signal 'promise, unresolved challenges' in finding effective dengue vaccine

Researchers clone T-cell receptor that binds to antigens associated with prostate and breast cancer

Study: 172K polymorphism makes certain forms of HIV less resistant to drugs

WHO says Nigeria not on track to turn back polio despite having tools, capacity

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in